Focus on The Path Forward for Orviglance
(PR-inside.com) MALMÖ, SE / ACCESS Newswire / August 20, 2026 / Ascelia Pharma (STO:ACE) today published its Half-Year Report for 2026 (January - June), which is now available on the company's website: Financial Reports - ASCELIA KEY EVENTS IN Q2 2026 Ascelia Pharma completed a directed share issue of SEK 20 million be…
Extrait seulement — cet éditeur protège son texte. Lisez le communiqué complet à la source.
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


